Event: ELCC 2021

0:02:16

Highlights from ELCC 2021

0:02:45

Exciting updates in radiotherapy at ELCC 2021

0:02:52

ELCC TELCA Trailer 2021

0:01:38

ELCC 2022: an opportunity for discussion and new perspectives

0:03:32

ELCC Film of the Day

0:00:49

ELCC 2022: importance of the multidisciplinary team

2:08:12

BEST OF ELCC ESMO BREAST 2024

0:19:21

Dr Ashish Joshi | Cancer Immunotherapy & Role of TECENTRIQ in 2LmNSCLC ELCC updates 2021

0:02:47

Mechanisms of acquired resistance against immunotherapy

0:09:00

Fulfilling unmet supportive care needs of patients with lung cancer

0:01:13

Brain metastases and lung cancer: optimizing treatment using biomarkers

0:01:27

Using clinical trials to drive treatment approaches in lung cancer

0:02:54

KRYSTAL-1: adagrasib for KRAS-mutant NSCLC

0:04:23

KEYNOTE-407: 3-year follow-up of pembrolizumab plus chemo in NSCLC

0:01:39

CAR-T therapy for lung cancer

1:03:44

Webinar: Redefining Resource Adequacy

0:02:53

KEYNOTE-407: pembrolizumab plus chemo improves OS and PFS in NSCLC

0:10:54

Dr Sachin Gupta | Management of NSC Lung Cancer ELCC Updates

0:04:55

Future perspectives on radiation oncology in lung cancer

0:01:43

Novel targets for NSCLC

0:01:49

ctDNA NGS for treatment decision-making in NSCLC

0:01:04

Describe a situation when you displayed your leadership qualities

0:01:45

Targeting RET in lung cancer

0:03:30

CheckMate 9LA: TMB and immune checkpoint inhibitor efficacy